Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-23-001570
Filing Date
2023-02-14
Accepted
2023-02-14 14:22:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 d9913774_13ga.htm SC 13G/A 119980
  Complete submission text file 0000919574-23-001570.txt   121485
Mailing Address 500 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 500 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 212-848-0519
SAMLYN CAPITAL, LLC (Filed by) CIK: 0001421097 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Subject) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92797 | Film No.: 23627100
SIC: 2834 Pharmaceutical Preparations